Articles On Stemcell United (ASX:SCU)
Title | Source | Codes | Date |
---|---|---|---|
ASX Health Stocks: BPH wants to ramp up bird’s nest sales to China
BPH Global about to ramp up China business ACL faces ACCC resistance on proposed takeover of Healius BPH Global to expand China business Health & wellness stock BPH Global (ASX:BP8) rose 20% after flagging a potential ramp up in Chi... |
Stockhead | SCU | 1 year ago |
Top 10 at 10: Tesserent surges 150pc after $176 million takeover by French multinational Thales
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | SCU | 1 year ago |
CLOSING BELL: Tech and Real Estate cop a right ol’ spanking as the market trips and falls 0.26%
Real estate, tech and specialty retail have all had a shocker on the way to an overall 0.26% fall Energy put up a 1.5% gain, with Utilities (+1.0%) and Materials (+0.6%) following it home Best of the Small Caps was Iceni Gold, after testin... |
Stockhead | SCU | 1 year ago |
Top 10 at 10: Check out these gold chunks
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | SCU | 1 year ago |
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week When we talk about dividend-paying hea... |
Stockhead | SCU | 1 year ago |
Top 10 at 10: WA1 scales new heights, REZ hits a shallow nickel orebody in the making
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | SCU | 1 year ago |
Weed Week: A ‘shroom boom’ could see psychedelics follow cannabis’ explosive footsteps
The world is experiencing a ‘shroom boom’ Psychedelics are expected to follow in cannabis’ explosive footstep And here’s how the ASX weed stocks have performed, sorted by winners over the past week For years, people have frowned upon ps... |
Stockhead | SCU | 1 year ago |
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough
Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May There are clear signs the biotech sector is springing back to life after a disappointing 2... |
Stockhead | SCU | 1 year ago |
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week Earlier this week, Pfizer surprised the market by say... |
Stockhead | SCU | 1 year ago |
Top 10 at 10: These ASX lithium, gas and biotech stocks are Hump Day heroes
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | SCU | 1 year ago |
Top 10 at 10: Which ASX gold and payment stocks are on a tear Tuesday?
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | SCU | 1 year ago |
Weed Week: Cannabis helps chronic pain and insomnia, and here’s what the TGA rules say
Research in Australia shows marijuana helps with chronic pain and insomnia The rules around getting prescriptions for medicinal cannabis A quick look at the winners and losers of ASX weed stocks Sufferers of chronic pain and insomnia ha... |
Stockhead | SCU | 1 year ago |
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?
The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit Medicare, telehealth and mental... |
Stockhead | SCU | 1 year ago |
CLOSING BELL: Welcome to the ASX, where our motto is ‘chin up, mate… it could’ve been worse’
‘More of the same’ since lunchtime saw the benchmark land at -0.25% for the day Health Care coughed up a 1.09% lift while Financials weighed heavily on -0.71% Magnum Mining wins the Small Caps trophy with +44.1% thanks to Mitsubishi deal... |
Stockhead | SCU | 1 year ago |
CLOSING BELL: The ASX dips while we ‘hurry up and wait’ to see what The Budget holds
ASX falls 0.17% ahead of Chalmers dropping The Budget on the nation Financials led the pack today, adding 0.5% on an otherwise fairly moribund day Voltaic Strategic Resources climbs 188% on pre-assay lithium results at Ti Tree The ASX h... |
Stockhead | SCU | 1 year ago |
Top 10 at 10: Investors love rare earths, hate giant cap raises
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | SCU | 1 year ago |
Weed Week: New studies confirm cannabis alleviates cancer pain, cuts need for opioids, and improves sleep
Studies confirm that cannabis relieves pain in cancer patients In addition, cannabis also improves sleep and cognitive function in cancer patients We take a look at the biggest movers in ASX weed stocks over the past week It’s now offic... |
Stockhead | SCU | 1 year ago |
ASX April Winners: Mid and small caps outperform blue-chip peers as gold stocks keep up rally
The S&P ASX 200 finished up 1.85% in April while mid and small caps outperformed their blue-chip peers Real estate topped the winning sectors for the month while tech stocks also rallied strongly in April Gold stocks continued solid ru... |
Stockhead | SCU | 1 year ago |
CLOSING BELL: No news is definitely good news among the Small Caps winners today
The benchmark kicked off well at +0.8% before deflating to finish on +0.4% Utilities (+1.21%)win the day, while InfoTech (-1.20%) takes a body blow. Lincoln Minerals (ASX:LML) tops the charts, up 36% for absolutely no reason at all. Loc... |
Stockhead | SCU | 1 year ago |
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales
Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s... |
Stockhead | SCU | 1 year ago |
Weed Week: 420 reminds us that cannabis stocks may be down, but by no means out
The 420 Day is unofficially the World Marijuana Day, and we look at the possible origins of this day Cannabis stocks have been falling, but there’s still a lot of promise We take a look at the cannabis stocks on the ASX over the past week... |
Stockhead | SCU | 1 year ago |
Top 10 at 10: A couple of oil and gas, lithium discoveries to get excited about
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | SCU | 1 year ago |
Weed Week: Most Aussies still use illicit cannabis, but more are now turning to prescriptions
The number of Aussies using legal instead of illicit medical cannabis is rising The main reason for using prescribed medicinal cannabis was chronic pain, says Sydney Uni survey We take a look at what made the news in ASX weed stocks this p... |
Stockhead | SCU | 1 year ago |
CLOSING BELL: ASX closes higher with Tech stocks leading the way
ASX closes up ~1%, while XEC rises 1.21% following global markets higher Rabobank expects the RBA to raise rates by 0.25% at its April meetig Alice Queen gets funding boost from Queensland Government for Horn Island exploration The posi... |
Stockhead | SCU | 1 year ago |
Top 10 at 10: Battery deals, high grades and a monster REE upgrade
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | SCU | 1 year ago |
WEED WEEK: Wellnex teams up with Chemist Warehouse for new cannabis products
Chemist Warehouse joins WNX JV to develop new cannabis products Neurotech launches new clinical program for its NTI164 drug in Rett Syndrome InhaleRx nabs approval for Phase 1 IRX211 clinical trial for Complex Regional Pain Syndrome Wel... |
Stockhead | SCU | 1 year ago |
Stemcell United (ASX:SCU) secures $1.02m through share placement in quest for ASX reinstatement
Stemcell United (SCU) secures $1.02 million through a share placement and convertible loan Institutional, professional and sophisticated investors have subscribed for over 145.8 million SCU shares at 0.6 cents each to raise up to $875,00... |
themarketherald.com.au | SCU | 1 year ago |
Weed Week: Musk gives the go-ahead for cannabis advertising on Twitter in the US
Twitter to allow cannabis companies to advertise in US states where it’s legal Elixnol comes out on top with CannaCare Health arbitration awarded in their favour Avecho expands CBD soft-gel capsule trials with the Lambert Initiative Twi... |
Stockhead | SCU | 1 year ago |
Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care
The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry The US FDA announced last week that:... |
Stockhead | SCU | 1 year ago |
Weed Week: Codeine demand drops when recreational cannabis is legal, study finds
US States who allow recreational cannabis see less codeine demand WA GP wants Snoop Dogg to drop into parliament to chat cannabis reform Neurotech nabs pre-submission meeting with US FDA for CBD drug NTI164 A Cornell University study ha... |
Stockhead | SCU | 1 year ago |
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past... |
Stockhead | SCU | 1 year ago |
Stemcell United (ASX:SCU) plans to shuffle board post capital raise
Stemcell United (SCU) plans board and management changes prior to a capital raising to satisfy ASX reinstatement conditions The company is looking to raise just over $1 million by the end of this month, which will be followed by CEO Phil... |
themarketherald.com.au | SCU | 1 year ago |
Weed Week: Decriminalising cannabis could save Aussie tax payers billions every year
Penington Institute says pot-related law enforcement costs us $1.7 billion a year Local cannabis is missing out on international and domestic market opportunities Aussie medicinal cannabis revenue was around $230 million in 2021 Decri... |
Stockhead | SCU | 2 years ago |
How out of favour Biotech has a PR problem and could learn from Dr Karl
ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and... |
Stockhead | SCU | 2 years ago |
Weed Week: More US states vote to legalise cannabis and Czech Republic to follow in Germany’s footsteps
Two more US states join the 19 that already allow legal recreational cannabis use ECS Botanics’ Victorian medical cannabis facility is safe from flooding in the state, so far Cann looks to commercialise its Satipharm CBD capsules for over-... |
Stockhead | SCU | 2 years ago |
Weed Week: Germany’s plans to legalise cannabis rekindle North American investment spark in Europe
Germany looks to legalise recreational cannabis and US and Canadian companies are paying attention Neurotech reports success with its cannabis-based drug for paediatric autism symptoms ECS Botanics has sold its Tasmanian business and a... |
Stockhead | SCU | 2 years ago |
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month There were 191 ASX IPOs in... |
Stockhead | SCU | 2 years ago |
Check Up: Blood clots are a $55bn opportunity and these 2 ASX stocks are vying for a slice
Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re... |
Stockhead | SCU | 2 years ago |
Stemcell United (ASX:SCU) signs MoU and JV deals
Plant-based biotech stock Stemcell United (SCU) signs two agreements with Singaporean companiesThe company will supply Baker’s Oven Pattisieries with up to S$2 million worth of seaweed-based products which will be infused into bakery items... |
themarketherald.com.au | SCU | 2 years ago |
Weed Week: The lazy stoner stereotype is a myth and this Aussie uni wants to study home grown cannabis
Cambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown cannabis in the ACT Incannex joins the big leagues S&P/ASX300 index It turns out that the lazy stoner stereotype is actually a myth,... |
Stockhead | SCU | 2 years ago |
Weed Week: Legal use of medicinal cannabis in Australia on the rise, Lambert Initiative says
Researchers say data shows transition from illicit to legal use of cannabis Medicinal users are at 37%, compared to 2.5% in 2018 Regulations, quality control and costs still barriers for legal week users New research from the University... |
Stockhead | SCU | 2 years ago |
Weed Week: Ice-T plans to open dispensary and Snoop Dogg’s venture capital firm backs weed snacks
Ice-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm led a seed funding round for TSUMo Snacks Incannex ramps up development and manufacturing of IHL-216A drug New Jersey has given Ice-T the gre... |
Stockhead | SCU | 2 years ago |
Weed Week: Aurora Marijuanis and CBD bubble tea in Thailand
Mysterious pink glow over Mildura Thailand businesses go nuts for CBD desserts and bubble tea ECS nabs $2m commercial loan facility to invest in new capacity ICYMI a mysterious pink glow above Mildura sent residents into a bit of a frenzy... |
Stockhead | SCU | 2 years ago |
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs
US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F... |
Stockhead | SCU | 2 years ago |
Weed Week: An Aussie medicinal cannabis farm for sale and crypto ATMs in weed dispensaries
ECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensaries in the US Zelira Therapeutics nabs regulatory approval in Germany for insomnia medication Ever fancied your own cannabis farm? Well, t... |
Stockhead | SCU | 2 years ago |
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit
A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m... |
Stockhead | SCU | 2 years ago |
Weed Week: Cannabis lounges in Las Vegas and Cann’s Mildura cannabis facility gets GMP licence
Retail and independent cannabis lounges could be opening soon in Vegas Cann Group gets good manufacturing practice (GMP) licence for its Mildura facility Bod plans to launch a low dose CBD schedule 3 product into the Australian market ... |
Stockhead | SCU | 2 years ago |
Weed Week: Cannabis-feed for chickens and cannabis campaigner nabs Queen’s Birthday honour
A Thai university says adding cannabis to chicken feed has positive results on meat and egg quality Aussie cannabis campaigner now a Member of the Order of Australia MGC Pharma’s CBD treatment proves effective against brain tumors Chian... |
Stockhead | SCU | 2 years ago |
Weed Week: Sydney Uni says it’s okay to CBD ‘n drive, and cannabis-infused drinks on the rise
Boston Beer Co launches cannabis iced tea in Canada University of Sydney says using CBD and driving is no worries Emyria reports positive Phase 1 study results for ultra-pure CBD capsule The Boston Beer Co is launching a line of cannabis-... |
Stockhead | SCU | 2 years ago |
Weed Week: Woody Harrelson opens weed dispensary and Byron Bay could be home to a cannabis resort
Actor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wellness retreat in Byron Bay Incannex wants to buy out APIRx It’s not surprising that Woody Harrelson loves weed – the actor was actually... |
Stockhead | SCU | 2 years ago |